These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21243821)

  • 1. [Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains].
    Copăcianu B; Tuchiluş C; Poiata A; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):896-9. PubMed ID: 21243821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
    Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended spectrum beta lactamase producing gram negative bacilli in a tertiary referral hospital of Assam--experience with two methods.
    Nath R; Saikia L; Mahanta J
    Indian J Pathol Microbiol; 2006 Oct; 49(4):623-5. PubMed ID: 17183880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended spectrum beta-lactamase producing organisms at the University Hospital of the West Indies.
    Nicholson AM; Gayle P; Roye-Green K
    West Indian Med J; 2004 Mar; 53(2):104-8. PubMed ID: 15199721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of ertapenem against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated in Spain.
    Hernández JR; Velasco C; Romero L; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Nov; 28(5):457-9. PubMed ID: 17008066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
    Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S
    Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS
    Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Pai H; Seo MR; Choi TY
    Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.
    Villegas MV; Correa A; Perez F; Miranda MC; Zuluaga T; Quinn JP;
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):217-22. PubMed ID: 15246513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
    Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
    Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.
    Jacoby GA; Walsh KE; Walker VJ
    J Clin Microbiol; 2006 Jun; 44(6):1971-6. PubMed ID: 16757586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
    FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
    Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
    J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.
    Thomson KS; Cornish NE; Hong SG; Hemrick K; Herdt C; Moland ES
    J Clin Microbiol; 2007 Aug; 45(8):2380-4. PubMed ID: 17596369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.